Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data

Therapeutic drug monitoring of ibrutinib is based on the area under the curve of concentration vs. time (AUC(IBRU)) instead of trough concentration (C(min,ss)) because of a limited accumulation in plasma. Our objective was to identify a limited sampling strategy (LSS) to estimate AUC(IBRU) associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Louedec, Félicien, Gallais, Fanny, Thomas, Fabienne, White-Koning, Mélanie, Allal, Ben, Protin, Caroline, Ysebaert, Loïc, Chatelut, Étienne, Puisset, Florent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922501/
https://www.ncbi.nlm.nih.gov/pubmed/33670575
http://dx.doi.org/10.3390/ph14020162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922501/
https://www.ncbi.nlm.nih.gov/pubmed/33670575
http://dx.doi.org/10.3390/ph14020162

Ejemplares similares